ScanSource, a leading technology distributor serving channel sales partners across hardware, software as a service (SaaS), connectivity, cloud, and services, entered this quarter with accelerating top-line momentum. Prior quarters showed revenue growth climbing from roughly 3% to 9% to 17%, and the first quarter of fiscal 2027 extended that trend sharply. Investors have been watching whether that volume growth could translate into profit, especially as the company integrates its roughly $218 million MicroAge acquisition, which closed on September 1, 2026. This report tests the durability of demand, the quality of margins, and management's ability to convert sales momentum into bottom-line performance. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
ScanSource reported first quarter fiscal 2027 results for the period ended September 30, 2026. Net sales climbed 30.1% year over year to $962.3 million, comfortably exceeding the consensus estimate near $860 million. Gross profit increased to $116.9 million, but gross margin declined 238 basis points to 12.2%, which management attributed to strong hardware demand and a heavier mix of lower-margin large deals.
On a GAAP (Generally Accepted Accounting Principles) basis, net income fell to $8.7 million, or $0.42 per diluted share, compared with $0.89 per diluted share in the prior-year quarter. Non-GAAP (adjusted) diluted EPS was $0.86, down 18.9% year over year and short of the roughly $1.12 consensus. Adjusted EBITDA declined 18.9% to $31.3 million, with an adjusted EBITDA margin of 3.25%, partly reflecting about $4.5 million of higher bad-debt expense tied to a Brazilian customer in judicial proceedings.
ScanSource raised its full-year fiscal 2027 outlook, now including MicroAge, to net sales of $3.8 billion to $4.0 billion and adjusted EBITDA of $175 million to $185 million, up from a prior range of $158 million to $165 million. Free cash flow guidance remained at "at least $85 million."
The stock fell sharply following the report, reflecting investor disappointment that 30% revenue growth did not flow through to earnings. The large non-GAAP EPS miss, the gross margin compression, and the first-quarter cash burn overshadowed the revenue beat and the higher full-year guidance. Sentiment centered on concerns that the guidance increase was driven largely by the MicroAge acquisition rather than a clear step-up in organic profitability, and that leverage rose as the company drew on its revolving credit facility to fund the deal. From what I see, this highlights how quickly the market can shift focus from top-line beats to bottom-line execution.
Looking ahead, investors will be watching whether ScanSource can convert its strong hardware demand into better profitability. The integration of MicroAge is a central focus, as the acquisition adds cloud, cybersecurity, data center, and artificial intelligence capabilities. Management has signaled a pilot to co-sell MicroAge's managed services through ScanSource's channel partners, which could support higher-margin recurring revenue over time.
Margin trends will be another key signal. The company's longer-term strategy targets building recurring revenue to a greater share of gross profit, which could help offset the mix pressure from large, lower-margin hardware deals. Any stabilization or improvement in gross margin would likely be viewed positively. I’m watching this closely as the company works through the acquisition integration.
Free cash flow remains a critical metric to monitor. The first quarter's $44.1 million cash burn, driven by working capital, means the company must generate substantial cash in the remaining three quarters to meet its "at least $85 million" target. Finally, investors should watch the higher-margin Intelisys and advisory segment, which remained sluggish, as a potential catalyst if recurring-revenue growth reaccelerates.
In reviewing the quarter, I turned to Tickeron’s AI Screener to quickly filter comparable distributors and spot pattern-based ideas that align with the reported trends. It helped surface a few names showing similar revenue momentum, which added useful context without replacing my own review of the numbers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
SCSC moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 35 of 47 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 74%.
The 10-day RSI Indicator for SCSC moved out of overbought territory on October 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In 31 of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCSC as a result. In 57 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for SCSC turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 30 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCSC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for SCSC entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCSC advanced for three days, in 216 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
SCSC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. SCSC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 39, placing this stock slightly worse than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.997) is normal, around the industry mean (2.294). P/E Ratio (12.214) is within average values for comparable stocks, (19.526). Projected Growth (PEG Ratio) (0.786) is also within normal values, averaging (1.350). Dividend Yield (0.000) settles around the average of (0.007) among similar stocks. P/S Ratio (0.381) is also within normal values, averaging (0.418).
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a distributer of specialty technology products
Industry ElectronicsApplianceStores